| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hodgkin Disease | 95 | 2018 | 1384 | 5.600 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 96 | 2016 | 11878 | 2.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 47 | 2016 | 1375 | 1.480 |
Why?
|
| Bleomycin | 38 | 2016 | 492 | 1.250 |
Why?
|
| Doxorubicin | 58 | 2016 | 2234 | 1.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 33 | 2014 | 1437 | 1.160 |
Why?
|
| Vincristine | 71 | 2016 | 1040 | 1.080 |
Why?
|
| Lymphoma | 46 | 2008 | 1898 | 1.060 |
Why?
|
| Vinblastine | 29 | 2014 | 487 | 1.000 |
Why?
|
| Medical Oncology | 8 | 2016 | 2346 | 0.960 |
Why?
|
| Prednisone | 66 | 2016 | 1567 | 0.820 |
Why?
|
| Procarbazine | 39 | 2016 | 172 | 0.740 |
Why?
|
| Mechlorethamine | 28 | 2016 | 129 | 0.690 |
Why?
|
| Cyclophosphamide | 60 | 2016 | 2227 | 0.690 |
Why?
|
| Dacarbazine | 18 | 2014 | 552 | 0.690 |
Why?
|
| Salvage Therapy | 15 | 2010 | 1273 | 0.660 |
Why?
|
| Leukemia, Myeloid | 35 | 1987 | 693 | 0.610 |
Why?
|
| Methotrexate | 42 | 2016 | 1721 | 0.610 |
Why?
|
| Immunoconjugates | 2 | 2018 | 975 | 0.580 |
Why?
|
| Famous Persons | 1 | 2016 | 109 | 0.470 |
Why?
|
| Radiotherapy | 8 | 2014 | 1502 | 0.470 |
Why?
|
| Antineoplastic Agents | 60 | 2015 | 13676 | 0.430 |
Why?
|
| Cytarabine | 13 | 2009 | 695 | 0.430 |
Why?
|
| Bone Marrow Transplantation | 22 | 1997 | 2709 | 0.410 |
Why?
|
| Leucovorin | 21 | 2008 | 643 | 0.410 |
Why?
|
| Combined Modality Therapy | 36 | 2014 | 8542 | 0.410 |
Why?
|
| Clinical Trials as Topic | 29 | 2016 | 8054 | 0.400 |
Why?
|
| Mediastinal Neoplasms | 11 | 2011 | 403 | 0.400 |
Why?
|
| Etoposide | 10 | 2014 | 639 | 0.400 |
Why?
|
| History, 20th Century | 7 | 2016 | 2766 | 0.360 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 483 | 0.320 |
Why?
|
| Breast Neoplasms | 30 | 2016 | 21206 | 0.300 |
Why?
|
| Immunologic Factors | 4 | 2009 | 1596 | 0.280 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2012 | 5717 | 0.280 |
Why?
|
| Disease-Free Survival | 18 | 2014 | 6847 | 0.280 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2009 | 240 | 0.280 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 1994 | 686 | 0.270 |
Why?
|
| Standard of Care | 1 | 2011 | 568 | 0.270 |
Why?
|
| Humans | 314 | 2022 | 768166 | 0.260 |
Why?
|
| Neoplasm Staging | 41 | 2014 | 11244 | 0.250 |
Why?
|
| Physicians | 2 | 2022 | 4598 | 0.250 |
Why?
|
| History, 21st Century | 3 | 2016 | 1573 | 0.250 |
Why?
|
| Remission Induction | 18 | 2011 | 2410 | 0.250 |
Why?
|
| Survival Analysis | 25 | 2009 | 10101 | 0.250 |
Why?
|
| Leukemia | 18 | 2006 | 1519 | 0.240 |
Why?
|
| Prognosis | 59 | 2011 | 30010 | 0.230 |
Why?
|
| Lymphocytes | 7 | 2009 | 2614 | 0.220 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 1994 | 98 | 0.220 |
Why?
|
| Drug Administration Schedule | 20 | 2016 | 4860 | 0.210 |
Why?
|
| Bone Marrow Diseases | 3 | 1994 | 234 | 0.210 |
Why?
|
| Hematology | 1 | 2006 | 243 | 0.200 |
Why?
|
| Societies, Medical | 3 | 2006 | 3968 | 0.190 |
Why?
|
| Burkitt Lymphoma | 11 | 2006 | 338 | 0.190 |
Why?
|
| Survival Rate | 18 | 2014 | 12840 | 0.180 |
Why?
|
| Carmustine | 6 | 1985 | 137 | 0.180 |
Why?
|
| Drug Evaluation | 16 | 1990 | 642 | 0.180 |
Why?
|
| Fluorouracil | 12 | 2016 | 1652 | 0.180 |
Why?
|
| Interdisciplinary Communication | 1 | 2006 | 937 | 0.170 |
Why?
|
| Treatment Outcome | 31 | 2014 | 65371 | 0.170 |
Why?
|
| Drug Therapy, Combination | 47 | 1983 | 6316 | 0.160 |
Why?
|
| Melphalan | 7 | 1994 | 421 | 0.160 |
Why?
|
| Blast Crisis | 2 | 1990 | 102 | 0.160 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 1907 | 0.160 |
Why?
|
| Adult | 153 | 2012 | 223646 | 0.150 |
Why?
|
| Amsacrine | 2 | 2016 | 19 | 0.150 |
Why?
|
| Female | 168 | 2016 | 397192 | 0.150 |
Why?
|
| Transplantation Conditioning | 3 | 2009 | 1601 | 0.150 |
Why?
|
| Middle Aged | 143 | 2012 | 223492 | 0.140 |
Why?
|
| Carcinoma, Small Cell | 4 | 1994 | 419 | 0.140 |
Why?
|
| Neoplasms | 30 | 2015 | 22371 | 0.140 |
Why?
|
| Asparaginase | 11 | 1972 | 240 | 0.140 |
Why?
|
| Dexamethasone | 12 | 2008 | 1965 | 0.140 |
Why?
|
| Remission, Spontaneous | 32 | 1979 | 384 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 9 | 2009 | 9263 | 0.130 |
Why?
|
| Gallium Radioisotopes | 3 | 1997 | 195 | 0.130 |
Why?
|
| Male | 153 | 2016 | 364719 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 13 | 2007 | 9419 | 0.130 |
Why?
|
| Life Tables | 1 | 2016 | 367 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2009 | 631 | 0.130 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2009 | 614 | 0.130 |
Why?
|
| Alkylating Agents | 8 | 1989 | 132 | 0.130 |
Why?
|
| Follow-Up Studies | 34 | 2011 | 39348 | 0.120 |
Why?
|
| Podophyllotoxin | 3 | 1984 | 20 | 0.120 |
Why?
|
| Leukemia, Lymphoid | 15 | 1987 | 311 | 0.120 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2016 | 300 | 0.120 |
Why?
|
| Reed-Sternberg Cells | 1 | 1994 | 78 | 0.120 |
Why?
|
| Prescription Fees | 1 | 2015 | 153 | 0.110 |
Why?
|
| Transplantation, Autologous | 13 | 1994 | 2120 | 0.110 |
Why?
|
| Italy | 1 | 2016 | 856 | 0.110 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1994 | 130 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2007 | 10760 | 0.110 |
Why?
|
| Bone Marrow | 29 | 1993 | 2935 | 0.110 |
Why?
|
| Topotecan | 2 | 2006 | 131 | 0.110 |
Why?
|
| Patient Advocacy | 1 | 2015 | 362 | 0.100 |
Why?
|
| Aged | 89 | 2012 | 171504 | 0.100 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 10 | 1985 | 45 | 0.100 |
Why?
|
| Positron-Emission Tomography | 4 | 2014 | 6669 | 0.100 |
Why?
|
| Publishing | 1 | 2000 | 837 | 0.100 |
Why?
|
| Gallium | 4 | 2004 | 30 | 0.100 |
Why?
|
| Splenectomy | 10 | 1991 | 392 | 0.100 |
Why?
|
| Abdominal Neoplasms | 4 | 1990 | 287 | 0.100 |
Why?
|
| Pneumonia | 1 | 2003 | 2163 | 0.100 |
Why?
|
| Therapeutic Human Experimentation | 1 | 1990 | 43 | 0.090 |
Why?
|
| Neoplasm Metastasis | 21 | 1997 | 4912 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 696 | 0.090 |
Why?
|
| Testicular Neoplasms | 9 | 1992 | 806 | 0.090 |
Why?
|
| Filgrastim | 1 | 2009 | 131 | 0.080 |
Why?
|
| Adolescent | 64 | 2011 | 89169 | 0.080 |
Why?
|
| Antigens, Neoplasm | 4 | 1993 | 1997 | 0.080 |
Why?
|
| Splenomegaly | 7 | 1990 | 192 | 0.080 |
Why?
|
| Cisplatin | 8 | 2002 | 1660 | 0.080 |
Why?
|
| Recurrence | 15 | 2007 | 8509 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1514 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2000 | 1465 | 0.080 |
Why?
|
| Research Subjects | 1 | 1990 | 249 | 0.080 |
Why?
|
| Astrocytoma | 1 | 1993 | 774 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 1560 | 0.080 |
Why?
|
| Health Personnel | 1 | 2022 | 3385 | 0.080 |
Why?
|
| Burnout, Professional | 2 | 2000 | 711 | 0.070 |
Why?
|
| Time Factors | 38 | 2011 | 40218 | 0.070 |
Why?
|
| Lung Diseases | 2 | 1991 | 1944 | 0.070 |
Why?
|
| Radiotherapy Dosage | 10 | 1999 | 2916 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2002 | 5341 | 0.070 |
Why?
|
| Transplantation, Homologous | 5 | 2008 | 4833 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 1999 | 3706 | 0.070 |
Why?
|
| Drug Costs | 1 | 2015 | 1195 | 0.070 |
Why?
|
| Arabinonucleosides | 1 | 2007 | 34 | 0.070 |
Why?
|
| Patient Selection | 2 | 2007 | 4260 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2014 | 20760 | 0.070 |
Why?
|
| Europe | 1 | 2014 | 3436 | 0.070 |
Why?
|
| Deoxycytidine | 3 | 2011 | 887 | 0.070 |
Why?
|
| Busulfan | 9 | 1985 | 259 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 1990 | 696 | 0.070 |
Why?
|
| Chromosome Aberrations | 10 | 1977 | 1778 | 0.070 |
Why?
|
| Patient Participation | 1 | 2015 | 1447 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 6514 | 0.060 |
Why?
|
| Lymphoma, Follicular | 2 | 2009 | 460 | 0.060 |
Why?
|
| Mitoguazone | 2 | 1982 | 11 | 0.060 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1985 | 136 | 0.060 |
Why?
|
| Leukopenia | 6 | 1999 | 212 | 0.060 |
Why?
|
| Interferons | 2 | 1987 | 720 | 0.060 |
Why?
|
| Lymphoma, B-Cell | 2 | 2006 | 945 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2007 | 125 | 0.060 |
Why?
|
| Cytogenetics | 4 | 1993 | 198 | 0.060 |
Why?
|
| Pelvic Neoplasms | 2 | 1983 | 250 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2007 | 210 | 0.060 |
Why?
|
| Guanidines | 2 | 1982 | 194 | 0.060 |
Why?
|
| United States | 13 | 2016 | 73039 | 0.060 |
Why?
|
| Thrombocytopenia | 8 | 2007 | 1179 | 0.060 |
Why?
|
| Hormones | 2 | 1986 | 866 | 0.060 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 2 | 2001 | 25 | 0.060 |
Why?
|
| Indoles | 1 | 2012 | 1836 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2002 | 1864 | 0.050 |
Why?
|
| Blood Transfusion | 3 | 1989 | 1309 | 0.050 |
Why?
|
| Mannitol | 3 | 1975 | 176 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2055 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2006 | 308 | 0.050 |
Why?
|
| Anthraquinones | 1 | 1983 | 41 | 0.050 |
Why?
|
| Antigens, CD | 2 | 1993 | 4035 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 427 | 0.050 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1986 | 410 | 0.050 |
Why?
|
| Boronic Acids | 1 | 2007 | 915 | 0.050 |
Why?
|
| Nitrogen Mustard Compounds | 8 | 1975 | 44 | 0.050 |
Why?
|
| Lymph Nodes | 12 | 2002 | 3474 | 0.050 |
Why?
|
| Zinostatin | 2 | 1979 | 7 | 0.050 |
Why?
|
| Aspartic Acid | 4 | 1980 | 577 | 0.050 |
Why?
|
| North America | 3 | 2005 | 1289 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2735 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 1999 | 388 | 0.050 |
Why?
|
| Retrospective Studies | 23 | 2010 | 81762 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 2 | 1990 | 1351 | 0.050 |
Why?
|
| Ovarian Neoplasms | 10 | 1989 | 4916 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2002 | 10399 | 0.050 |
Why?
|
| Sirolimus | 1 | 2008 | 1540 | 0.050 |
Why?
|
| Vomiting, Anticipatory | 1 | 2001 | 2 | 0.050 |
Why?
|
| Pyrazines | 1 | 2007 | 1205 | 0.050 |
Why?
|
| Lung Neoplasms | 12 | 2002 | 13586 | 0.050 |
Why?
|
| Brain Neoplasms | 6 | 1993 | 9118 | 0.050 |
Why?
|
| Phosphonoacetic Acid | 1 | 1980 | 54 | 0.050 |
Why?
|
| Actuarial Analysis | 5 | 1995 | 370 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 1983 | 2846 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 1126 | 0.040 |
Why?
|
| Lymphatic Metastasis | 9 | 1993 | 2914 | 0.040 |
Why?
|
| Leukocyte Count | 9 | 1983 | 1609 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 5 | 1995 | 3409 | 0.040 |
Why?
|
| Philadelphia Chromosome | 3 | 1993 | 119 | 0.040 |
Why?
|
| Bone Neoplasms | 6 | 1985 | 2565 | 0.040 |
Why?
|
| Hypercalcemia | 2 | 1974 | 424 | 0.040 |
Why?
|
| Age Factors | 9 | 2002 | 18412 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1596 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 1980 | 211 | 0.040 |
Why?
|
| Diploidy | 3 | 1977 | 140 | 0.040 |
Why?
|
| Castration | 4 | 1982 | 149 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2002 | 714 | 0.040 |
Why?
|
| Nausea | 3 | 2001 | 682 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 4 | 2009 | 1061 | 0.040 |
Why?
|
| Asparagine | 6 | 1972 | 120 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 2230 | 0.040 |
Why?
|
| Splenic Artery | 1 | 1979 | 58 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 4 | 1991 | 542 | 0.040 |
Why?
|
| Mastectomy | 6 | 1986 | 1861 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1996 | 2000 | 0.040 |
Why?
|
| Anemia, Hemolytic | 1 | 1979 | 164 | 0.040 |
Why?
|
| Nitrosourea Compounds | 6 | 1977 | 32 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 1979 | 681 | 0.040 |
Why?
|
| Infusions, Parenteral | 3 | 1983 | 396 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 620 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2001 | 368 | 0.040 |
Why?
|
| Glioma | 1 | 1993 | 3503 | 0.040 |
Why?
|
| Proportional Hazards Models | 4 | 2002 | 12543 | 0.040 |
Why?
|
| Diaphragm | 2 | 1990 | 357 | 0.040 |
Why?
|
| Immunotoxins | 1 | 1998 | 175 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2002 | 1622 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 13 | 1987 | 3626 | 0.030 |
Why?
|
| Adaptation, Psychological | 3 | 2000 | 2663 | 0.030 |
Why?
|
| Neutropenia | 3 | 2007 | 892 | 0.030 |
Why?
|
| Immunotherapy | 3 | 2009 | 4755 | 0.030 |
Why?
|
| Drug Therapy | 1 | 1999 | 504 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2008 | 3049 | 0.030 |
Why?
|
| Adenocarcinoma | 8 | 1982 | 6395 | 0.030 |
Why?
|
| B-Lymphocytes | 6 | 1989 | 4793 | 0.030 |
Why?
|
| Drug Resistance | 6 | 1991 | 1599 | 0.030 |
Why?
|
| Selection Bias | 1 | 1997 | 360 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4206 | 0.030 |
Why?
|
| Bone Marrow Examination | 6 | 1978 | 154 | 0.030 |
Why?
|
| Child | 35 | 2002 | 80917 | 0.030 |
Why?
|
| Histamine | 1 | 1977 | 496 | 0.030 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2004 | 928 | 0.030 |
Why?
|
| Hematopoiesis | 4 | 1994 | 2059 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 1525 | 0.030 |
Why?
|
| Hydroxyurea | 5 | 1976 | 284 | 0.030 |
Why?
|
| Treatment Failure | 3 | 2009 | 2661 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1980 | 591 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 1980 | 612 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 6 | 1988 | 1627 | 0.030 |
Why?
|
| Hemolysis | 2 | 1974 | 417 | 0.030 |
Why?
|
| Radiography | 5 | 1991 | 6983 | 0.030 |
Why?
|
| Thrombocytosis | 1 | 1974 | 88 | 0.030 |
Why?
|
| Quality of Life | 5 | 2001 | 13490 | 0.030 |
Why?
|
| Megestrol | 1 | 1993 | 9 | 0.030 |
Why?
|
| Ligases | 3 | 1970 | 333 | 0.030 |
Why?
|
| Thymidine | 2 | 1980 | 297 | 0.030 |
Why?
|
| Leukocytosis | 1 | 1975 | 251 | 0.030 |
Why?
|
| Drug Synergism | 5 | 2009 | 1760 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 2 | 1981 | 616 | 0.030 |
Why?
|
| Radiation Dosage | 2 | 2002 | 1967 | 0.030 |
Why?
|
| Erythrocytes | 3 | 1983 | 2418 | 0.030 |
Why?
|
| Leukocytes | 6 | 1983 | 2035 | 0.030 |
Why?
|
| Mammography | 2 | 2002 | 2433 | 0.030 |
Why?
|
| Mesothelioma | 1 | 1980 | 811 | 0.030 |
Why?
|
| Disease Progression | 3 | 2008 | 13671 | 0.030 |
Why?
|
| Menopause | 4 | 1988 | 1656 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 1980 | 714 | 0.030 |
Why?
|
| Sick Role | 1 | 1994 | 229 | 0.030 |
Why?
|
| Young Adult | 5 | 2011 | 60066 | 0.030 |
Why?
|
| Chlorambucil | 2 | 1989 | 42 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 1996 | 3556 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1992 | 498 | 0.030 |
Why?
|
| Antigens, Surface | 4 | 1985 | 1617 | 0.030 |
Why?
|
| Aneuploidy | 3 | 1990 | 573 | 0.030 |
Why?
|
| Choriocarcinoma | 4 | 1983 | 121 | 0.030 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1985 | 263 | 0.030 |
Why?
|
| Antigens, CD20 | 2 | 2009 | 199 | 0.020 |
Why?
|
| Adrenalectomy | 3 | 1980 | 348 | 0.020 |
Why?
|
| Emergencies | 1 | 1978 | 1221 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 1971 | 71 | 0.020 |
Why?
|
| Spleen | 4 | 1987 | 2295 | 0.020 |
Why?
|
| Benzoates | 1 | 1973 | 213 | 0.020 |
Why?
|
| Survivors | 2 | 2002 | 2381 | 0.020 |
Why?
|
| Hyperkalemia | 2 | 1974 | 234 | 0.020 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 1971 | 31 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1991 | 213 | 0.020 |
Why?
|
| Ultrasonography | 2 | 1983 | 6004 | 0.020 |
Why?
|
| Estrogen Antagonists | 2 | 1982 | 151 | 0.020 |
Why?
|
| Prednisolone | 2 | 1989 | 326 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2006 | 3463 | 0.020 |
Why?
|
| Blood Cell Count | 5 | 1977 | 406 | 0.020 |
Why?
|
| Erythropoiesis | 2 | 1985 | 691 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1970 | 530 | 0.020 |
Why?
|
| Child, Preschool | 16 | 2002 | 42669 | 0.020 |
Why?
|
| Glutamine | 2 | 1970 | 577 | 0.020 |
Why?
|
| Meninges | 2 | 1975 | 197 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14729 | 0.020 |
Why?
|
| Estrogens | 2 | 1988 | 1536 | 0.020 |
Why?
|
| Hypophysectomy | 2 | 1980 | 114 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 4 | 1991 | 594 | 0.020 |
Why?
|
| Meningeal Neoplasms | 2 | 1983 | 1253 | 0.020 |
Why?
|
| Time | 1 | 1991 | 552 | 0.020 |
Why?
|
| Prospective Studies | 12 | 2012 | 54926 | 0.020 |
Why?
|
| Androgens | 2 | 1988 | 1281 | 0.020 |
Why?
|
| Bone Diseases | 2 | 1971 | 416 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 1969 | 53 | 0.020 |
Why?
|
| Aged, 80 and over | 6 | 2011 | 59629 | 0.020 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1970 | 96 | 0.020 |
Why?
|
| Interferon-alpha | 2 | 2009 | 910 | 0.020 |
Why?
|
| Urea | 1 | 1971 | 448 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 1969 | 225 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 1994 | 1082 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 1970 | 296 | 0.020 |
Why?
|
| Kidney Neoplasms | 2 | 1982 | 4282 | 0.020 |
Why?
|
| Laparotomy | 5 | 1995 | 458 | 0.020 |
Why?
|
| Axilla | 2 | 1993 | 623 | 0.020 |
Why?
|
| Retroperitoneal Neoplasms | 4 | 1988 | 335 | 0.020 |
Why?
|
| Calcineurin | 1 | 2008 | 235 | 0.020 |
Why?
|
| Floxuridine | 1 | 1967 | 44 | 0.020 |
Why?
|
| Bone Marrow Cells | 6 | 1983 | 2414 | 0.020 |
Why?
|
| Central Nervous System Diseases | 3 | 1990 | 520 | 0.020 |
Why?
|
| Random Allocation | 2 | 2004 | 2396 | 0.020 |
Why?
|
| Heart | 1 | 1980 | 4446 | 0.020 |
Why?
|
| Caregivers | 1 | 2000 | 2302 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1969 | 1310 | 0.020 |
Why?
|
| Dysgerminoma | 2 | 1983 | 66 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1993 | 1667 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9538 | 0.020 |
Why?
|
| Liver Neoplasms | 6 | 1978 | 4362 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 3 | 1983 | 506 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1967 | 133 | 0.020 |
Why?
|
| Thioguanine | 3 | 1976 | 45 | 0.020 |
Why?
|
| Anemia, Aplastic | 2 | 1983 | 231 | 0.020 |
Why?
|
| Nucleosides | 1 | 1967 | 130 | 0.020 |
Why?
|
| Acute Disease | 5 | 1990 | 7243 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1969 | 677 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 1987 | 156 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1989 | 5505 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2002 | 15948 | 0.020 |
Why?
|
| Injections, Intravenous | 6 | 1975 | 1377 | 0.020 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2006 | 70 | 0.020 |
Why?
|
| Research | 1 | 1994 | 1979 | 0.020 |
Why?
|
| Teratoma | 2 | 1983 | 405 | 0.020 |
Why?
|
| Phenotype | 4 | 1993 | 16726 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2006 | 5953 | 0.020 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1985 | 64 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1986 | 85 | 0.020 |
Why?
|
| Flutamide | 1 | 1986 | 95 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1982 | 2560 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2008 | 594 | 0.020 |
Why?
|
| Health Care Reform | 1 | 1994 | 1256 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 1986 | 195 | 0.020 |
Why?
|
| Cell Line | 3 | 1994 | 15597 | 0.020 |
Why?
|
| Receptors, Estrogen | 2 | 1986 | 2253 | 0.010 |
Why?
|
| Interferon Type I | 1 | 1989 | 569 | 0.010 |
Why?
|
| Prodrugs | 1 | 2007 | 274 | 0.010 |
Why?
|
| Risk Factors | 5 | 2002 | 74944 | 0.010 |
Why?
|
| Logistic Models | 2 | 1998 | 13290 | 0.010 |
Why?
|
| Primary Myelofibrosis | 3 | 1975 | 209 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1985 | 169 | 0.010 |
Why?
|
| Freezing | 1 | 1985 | 311 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 3 | 1983 | 1164 | 0.010 |
Why?
|
| T-Lymphocytes | 4 | 1986 | 10266 | 0.010 |
Why?
|
| Progestins | 1 | 1986 | 302 | 0.010 |
Why?
|
| Megakaryocytes | 2 | 1985 | 571 | 0.010 |
Why?
|
| Hematologic Diseases | 3 | 1995 | 498 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1978 | 2333 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 3 | 1973 | 189 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1985 | 319 | 0.010 |
Why?
|
| Tamoxifen | 1 | 1988 | 966 | 0.010 |
Why?
|
| Cataract | 1 | 1969 | 837 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 1988 | 957 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1966 | 540 | 0.010 |
Why?
|
| Mitoxantrone | 1 | 1983 | 148 | 0.010 |
Why?
|
| Leukemia, Radiation-Induced | 2 | 1985 | 36 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1986 | 11101 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2002 | 5432 | 0.010 |
Why?
|
| Escherichia coli | 5 | 1972 | 4214 | 0.010 |
Why?
|
| Radioisotopes | 2 | 1974 | 517 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 1982 | 794 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2002 | 228 | 0.010 |
Why?
|
| Blood Platelets | 6 | 1977 | 2479 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1982 | 198 | 0.010 |
Why?
|
| Calcium | 2 | 1991 | 5792 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1984 | 738 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1196 | 0.010 |
Why?
|
| Twins, Monozygotic | 2 | 1979 | 472 | 0.010 |
Why?
|
| Vitamin B 12 | 2 | 1976 | 529 | 0.010 |
Why?
|
| Cell Separation | 1 | 1987 | 1728 | 0.010 |
Why?
|
| Probability | 3 | 1996 | 2479 | 0.010 |
Why?
|
| Lymphography | 4 | 1990 | 189 | 0.010 |
Why?
|
| Predictive Value of Tests | 4 | 2002 | 15454 | 0.010 |
Why?
|
| Boston | 2 | 2008 | 9374 | 0.010 |
Why?
|
| Platelet Count | 1 | 1983 | 787 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1981 | 121 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 227 | 0.010 |
Why?
|
| Cholesterol | 2 | 1969 | 2914 | 0.010 |
Why?
|
| Sarcoma | 2 | 1983 | 1806 | 0.010 |
Why?
|
| Aminoglutethimide | 1 | 1980 | 13 | 0.010 |
Why?
|
| Liver | 8 | 1979 | 7577 | 0.010 |
Why?
|
| Diagnostic Errors | 2 | 1985 | 1281 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 1990 | 11669 | 0.010 |
Why?
|
| Glaucarubin | 1 | 1979 | 3 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 24315 | 0.010 |
Why?
|
| Folic Acid | 1 | 1967 | 1337 | 0.010 |
Why?
|
| Methods | 3 | 1988 | 1066 | 0.010 |
Why?
|
| Stress, Psychological | 3 | 2001 | 4530 | 0.010 |
Why?
|
| Creatinine | 2 | 1979 | 1918 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1983 | 528 | 0.010 |
Why?
|
| Oncogenes | 1 | 1985 | 1234 | 0.010 |
Why?
|
| Maryland | 3 | 1977 | 278 | 0.010 |
Why?
|
| Pyrans | 1 | 1979 | 49 | 0.010 |
Why?
|
| Drug Combinations | 2 | 1977 | 2089 | 0.010 |
Why?
|
| Radiation Injuries | 2 | 1985 | 1198 | 0.010 |
Why?
|
| Karyotyping | 3 | 1983 | 1177 | 0.010 |
Why?
|
| Biopsy | 6 | 2002 | 6793 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 1986 | 1089 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1979 | 181 | 0.010 |
Why?
|
| Cytokines | 1 | 1994 | 7453 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1982 | 1765 | 0.010 |
Why?
|
| Pilot Projects | 3 | 1995 | 8741 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1970 | 458 | 0.010 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1979 | 187 | 0.010 |
Why?
|
| Urogenital Neoplasms | 1 | 1980 | 130 | 0.010 |
Why?
|
| Alopecia | 3 | 1983 | 416 | 0.010 |
Why?
|
| Skin Neoplasms | 4 | 1976 | 5863 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1983 | 1419 | 0.010 |
Why?
|
| Infection Control | 1 | 1985 | 985 | 0.010 |
Why?
|
| Asbestos | 1 | 1980 | 251 | 0.010 |
Why?
|
| Body Weight | 1 | 1989 | 4627 | 0.010 |
Why?
|
| Immunoassay | 1 | 2002 | 746 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6526 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 4 | 1981 | 2931 | 0.010 |
Why?
|
| Lomustine | 1 | 1977 | 60 | 0.010 |
Why?
|
| Neoplasms, Experimental | 2 | 1980 | 1230 | 0.010 |
Why?
|
| Chronic Disease | 4 | 1975 | 9384 | 0.010 |
Why?
|
| Streptozocin | 1 | 1977 | 190 | 0.010 |
Why?
|
| Maytansine | 1 | 1978 | 88 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2003 | 2923 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1980 | 659 | 0.010 |
Why?
|
| Potassium | 2 | 1973 | 1315 | 0.010 |
Why?
|
| Leukemia L1210 | 2 | 1975 | 44 | 0.010 |
Why?
|
| Animals | 12 | 1988 | 169246 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 1993 | 5196 | 0.010 |
Why?
|
| Altretamine | 3 | 1985 | 11 | 0.010 |
Why?
|
| Radiation Pneumonitis | 1 | 1997 | 100 | 0.010 |
Why?
|
| Fluoxymesterone | 1 | 1996 | 12 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1982 | 19015 | 0.010 |
Why?
|
| Thiotepa | 1 | 1996 | 66 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1986 | 6340 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1985 | 2323 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1986 | 2819 | 0.010 |
Why?
|
| Cyclohexanes | 2 | 1974 | 151 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1977 | 206 | 0.010 |
Why?
|
| Mesna | 1 | 1995 | 62 | 0.010 |
Why?
|
| Fibrosarcoma | 2 | 1975 | 313 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3728 | 0.010 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1975 | 48 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1979 | 622 | 0.010 |
Why?
|
| Palliative Care | 2 | 1988 | 3643 | 0.010 |
Why?
|
| Oxazines | 1 | 1978 | 358 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 1981 | 683 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1975 | 58 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1976 | 863 | 0.010 |
Why?
|
| Adenoma, Islet Cell | 1 | 1975 | 72 | 0.010 |
Why?
|
| Azauridine | 1 | 1974 | 2 | 0.010 |
Why?
|
| Mitolactol | 1 | 1974 | 13 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1975 | 98 | 0.010 |
Why?
|
| Kidney | 3 | 1980 | 7064 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1974 | 54 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
|
| Basophils | 1 | 1977 | 407 | 0.010 |
Why?
|
| Methemoglobin | 1 | 1974 | 25 | 0.010 |
Why?
|
| Osmotic Fragility | 1 | 1974 | 35 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 1981 | 4058 | 0.010 |
Why?
|
| Transferrin | 2 | 1976 | 283 | 0.010 |
Why?
|
| Skin Diseases | 2 | 1980 | 1085 | 0.010 |
Why?
|
| Death, Sudden | 2 | 1974 | 301 | 0.010 |
Why?
|
| Melanoma | 4 | 1974 | 5706 | 0.010 |
Why?
|
| Glucose | 1 | 1966 | 4352 | 0.010 |
Why?
|
| Megestrol Acetate | 1 | 1993 | 18 | 0.010 |
Why?
|
| Diagnosis, Differential | 4 | 1997 | 13014 | 0.010 |
Why?
|
| Hydrazones | 1 | 1974 | 105 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1974 | 94 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1977 | 381 | 0.010 |
Why?
|
| Diarrhea | 1 | 1980 | 1320 | 0.010 |
Why?
|
| Ferritins | 1 | 1976 | 601 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1975 | 1142 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1974 | 367 | 0.010 |
Why?
|
| Half-Life | 1 | 1974 | 651 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 1975 | 280 | 0.010 |
Why?
|
| Pregnancy | 3 | 1982 | 30256 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1972 | 157 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1973 | 189 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1993 | 163 | 0.010 |
Why?
|
| Bromine | 1 | 1972 | 23 | 0.010 |
Why?
|
| Blood Protein Disorders | 1 | 1971 | 8 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1140 | 0.010 |
Why?
|
| Glutathione | 1 | 1974 | 589 | 0.010 |
Why?
|
| Anemia, Macrocytic | 1 | 1971 | 53 | 0.010 |
Why?
|
| Personality Assessment | 1 | 1994 | 646 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3436 | 0.010 |
Why?
|
| Appetite | 1 | 1993 | 247 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1971 | 94 | 0.010 |
Why?
|
| Allopurinol | 1 | 1973 | 202 | 0.010 |
Why?
|
| Cause of Death | 1 | 2002 | 3721 | 0.010 |
Why?
|
| Esterases | 1 | 1971 | 89 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1971 | 141 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1975 | 484 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1996 | 1826 | 0.010 |
Why?
|
| Cranial Irradiation | 1 | 1994 | 393 | 0.010 |
Why?
|
| Peroxidases | 1 | 1971 | 135 | 0.010 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1992 | 193 | 0.010 |
Why?
|
| Diplopia | 1 | 1972 | 217 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1974 | 740 | 0.010 |
Why?
|
| Azaserine | 1 | 1970 | 8 | 0.010 |
Why?
|
| beta-Aminoethyl Isothiourea | 1 | 1970 | 1 | 0.010 |
Why?
|
| Chloromercuribenzoates | 1 | 1970 | 5 | 0.010 |
Why?
|
| Administration, Oral | 3 | 1975 | 4030 | 0.010 |
Why?
|
| Glycogen | 1 | 1971 | 252 | 0.010 |
Why?
|
| Puromycin | 1 | 1970 | 41 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1974 | 526 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1992 | 643 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1992 | 400 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1992 | 635 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1971 | 699 | 0.010 |
Why?
|
| Bromides | 1 | 1969 | 21 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1970 | 114 | 0.010 |
Why?
|
| Chromatography | 1 | 1969 | 189 | 0.010 |
Why?
|
| Azo Compounds | 1 | 1970 | 116 | 0.010 |
Why?
|
| Sulfonic Acids | 1 | 1970 | 103 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1982 | 3329 | 0.010 |
Why?
|
| Hematocrit | 2 | 1987 | 623 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1983 | 3114 | 0.010 |
Why?
|
| Risk | 2 | 1996 | 9613 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1974 | 870 | 0.010 |
Why?
|
| Lactates | 1 | 1970 | 401 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 318 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1979 | 1481 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1974 | 3055 | 0.000 |
Why?
|
| Bile Acids and Salts | 1 | 1971 | 398 | 0.000 |
Why?
|
| Clone Cells | 1 | 1972 | 1670 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1991 | 41754 | 0.000 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1994 | 1791 | 0.000 |
Why?
|
| Infant | 3 | 1995 | 36535 | 0.000 |
Why?
|
| Albumins | 1 | 1971 | 577 | 0.000 |
Why?
|
| Sex Factors | 2 | 1998 | 10632 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1974 | 2227 | 0.000 |
Why?
|
| Colchicine | 1 | 1969 | 257 | 0.000 |
Why?
|
| Digestive System | 2 | 1979 | 244 | 0.000 |
Why?
|
| Splenic Neoplasms | 1 | 1988 | 97 | 0.000 |
Why?
|
| Myocardium | 1 | 1980 | 4788 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1971 | 891 | 0.000 |
Why?
|
| Phosphates | 1 | 1971 | 765 | 0.000 |
Why?
|
| Lens, Crystalline | 1 | 1969 | 387 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1971 | 1081 | 0.000 |
Why?
|
| Carcinogens | 1 | 1969 | 453 | 0.000 |
Why?
|
| Mice | 6 | 1982 | 82029 | 0.000 |
Why?
|
| Neurologic Manifestations | 1 | 1966 | 19 | 0.000 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1989 | 547 | 0.000 |
Why?
|
| Skull | 1 | 1971 | 820 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 3269 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1989 | 855 | 0.000 |
Why?
|
| Mitobronitol | 1 | 1985 | 3 | 0.000 |
Why?
|
| Serotonin | 1 | 1971 | 1043 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1971 | 880 | 0.000 |
Why?
|
| Laparoscopy | 3 | 1989 | 2041 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1971 | 587 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1981 | 3464 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1991 | 863 | 0.000 |
Why?
|
| Teniposide | 1 | 1985 | 11 | 0.000 |
Why?
|
| Interleukin-4 | 1 | 1989 | 1156 | 0.000 |
Why?
|
| Fever | 2 | 1979 | 1614 | 0.000 |
Why?
|
| Anemia | 1 | 1974 | 1514 | 0.000 |
Why?
|
| South America | 2 | 1975 | 180 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1980 | 4543 | 0.000 |
Why?
|
| Mouth Neoplasms | 1 | 1970 | 597 | 0.000 |
Why?
|
| HIV Infections | 1 | 1991 | 17569 | 0.000 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1972 | 1126 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1994 | 2430 | 0.000 |
Why?
|
| Uganda | 1 | 1969 | 1361 | 0.000 |
Why?
|
| Cell Survival | 1 | 1974 | 5777 | 0.000 |
Why?
|
| Rats | 1 | 1980 | 23760 | 0.000 |
Why?
|
| Cell Division | 1 | 1972 | 4473 | 0.000 |
Why?
|
| Mesonephroma | 1 | 1983 | 21 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1998 | 7852 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1995 | 5315 | 0.000 |
Why?
|
| Amino Acids | 1 | 1970 | 1716 | 0.000 |
Why?
|
| Lung | 1 | 1982 | 10099 | 0.000 |
Why?
|
| Linear Models | 1 | 1993 | 5884 | 0.000 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1985 | 242 | 0.000 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1974 | 1481 | 0.000 |
Why?
|
| Weight Gain | 1 | 1993 | 2359 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1985 | 876 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1983 | 351 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1975 | 2541 | 0.000 |
Why?
|
| Smoking | 1 | 1980 | 9092 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1972 | 1398 | 0.000 |
Why?
|
| Vinca Alkaloids | 2 | 1972 | 36 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 2 | 1981 | 1206 | 0.000 |
Why?
|
| Spermatogenesis | 2 | 1974 | 260 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1982 | 175 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1971 | 1886 | 0.000 |
Why?
|
| Organ Size | 1 | 1967 | 2267 | 0.000 |
Why?
|
| Registries | 1 | 1998 | 8375 | 0.000 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1983 | 897 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1963 | 447 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 3620 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 1561 | 0.000 |
Why?
|
| Autopsy | 2 | 1975 | 1011 | 0.000 |
Why?
|
| Thymidine Phosphorylase | 1 | 1980 | 16 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1970 | 3655 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1980 | 84 | 0.000 |
Why?
|
| Quassins | 1 | 1979 | 6 | 0.000 |
Why?
|
| Stem Cells | 1 | 1993 | 3537 | 0.000 |
Why?
|
| Thymine | 1 | 1980 | 69 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 12077 | 0.000 |
Why?
|
| Lipids | 1 | 1971 | 3343 | 0.000 |
Why?
|
| Thymidine Kinase | 1 | 1980 | 286 | 0.000 |
Why?
|
| Immunity | 2 | 1977 | 1003 | 0.000 |
Why?
|
| Interphase | 1 | 1979 | 227 | 0.000 |
Why?
|
| Pedigree | 2 | 1981 | 4539 | 0.000 |
Why?
|
| Abdomen | 2 | 1975 | 1136 | 0.000 |
Why?
|
| Acute Kidney Injury | 1 | 1971 | 1942 | 0.000 |
Why?
|
| Carcinoma | 1 | 1970 | 2332 | 0.000 |
Why?
|
| Uremia | 2 | 1969 | 202 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1987 | 2121 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1983 | 1334 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1975 | 5446 | 0.000 |
Why?
|
| Erythroblasts | 1 | 1977 | 142 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1983 | 1321 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1983 | 1801 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 2 | 1969 | 350 | 0.000 |
Why?
|
| Graft Survival | 1 | 1987 | 3887 | 0.000 |
Why?
|
| Carcinoma 256, Walker | 1 | 1975 | 37 | 0.000 |
Why?
|
| Indium | 1 | 1975 | 47 | 0.000 |
Why?
|
| Lethal Dose 50 | 1 | 1975 | 71 | 0.000 |
Why?
|
| Kinetics | 2 | 1974 | 6329 | 0.000 |
Why?
|
| Thallium | 1 | 1975 | 100 | 0.000 |
Why?
|
| Africa, Eastern | 1 | 1975 | 76 | 0.000 |
Why?
|
| Maxillary Neoplasms | 1 | 1975 | 47 | 0.000 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1975 | 177 | 0.000 |
Why?
|
| Aluminum | 1 | 1975 | 150 | 0.000 |
Why?
|
| Nervous System | 1 | 1978 | 544 | 0.000 |
Why?
|
| Cardiovascular Diseases | 2 | 1995 | 15662 | 0.000 |
Why?
|
| Killer Cells, Natural | 1 | 1983 | 2211 | 0.000 |
Why?
|
| Mandibular Neoplasms | 1 | 1975 | 131 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1981 | 1793 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1975 | 412 | 0.000 |
Why?
|
| Nitrates | 1 | 1975 | 260 | 0.000 |
Why?
|
| Body Surface Area | 1 | 1974 | 205 | 0.000 |
Why?
|
| Inclusion Bodies | 1 | 1975 | 278 | 0.000 |
Why?
|
| Hypotension | 1 | 1979 | 888 | 0.000 |
Why?
|
| Haplorhini | 1 | 1974 | 523 | 0.000 |
Why?
|
| Hematopoietic System | 1 | 1973 | 110 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1976 | 498 | 0.000 |
Why?
|
| Incidence | 1 | 1991 | 21538 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1983 | 5902 | 0.000 |
Why?
|
| Macaca | 1 | 1974 | 413 | 0.000 |
Why?
|
| Intestinal Neoplasms | 1 | 1975 | 314 | 0.000 |
Why?
|
| Pancreatitis | 2 | 1969 | 1087 | 0.000 |
Why?
|
| Cobalt Isotopes | 1 | 1971 | 5 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1971 | 66 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1971 | 81 | 0.000 |
Why?
|
| Chlorides | 1 | 1975 | 666 | 0.000 |
Why?
|
| Retroviridae | 1 | 1974 | 846 | 0.000 |
Why?
|
| Amidohydrolases | 1 | 1972 | 160 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1971 | 293 | 0.000 |
Why?
|
| Crystallization | 1 | 1972 | 520 | 0.000 |
Why?
|
| Erythrocyte Count | 1 | 1971 | 157 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1972 | 646 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1970 | 7477 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1977 | 1531 | 0.000 |
Why?
|
| Methylcellulose | 1 | 1970 | 34 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1971 | 287 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1973 | 727 | 0.000 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1971 | 119 | 0.000 |
Why?
|
| Infertility, Male | 1 | 1974 | 397 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1973 | 822 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1975 | 1505 | 0.000 |
Why?
|
| Abscess | 1 | 1974 | 606 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1981 | 2100 | 0.000 |
Why?
|
| Vomiting | 1 | 1973 | 655 | 0.000 |
Why?
|
| Osteomyelitis | 1 | 1974 | 408 | 0.000 |
Why?
|
| Amylases | 1 | 1969 | 171 | 0.000 |
Why?
|
| Genes, Recessive | 1 | 1971 | 625 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 36743 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1975 | 1217 | 0.000 |
Why?
|
| Metabolic Diseases | 1 | 1975 | 684 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1974 | 724 | 0.000 |
Why?
|
| Ovary | 1 | 1972 | 965 | 0.000 |
Why?
|
| Bilirubin | 1 | 1969 | 438 | 0.000 |
Why?
|
| Iron | 1 | 1976 | 1813 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1979 | 2043 | 0.000 |
Why?
|
| Hysterectomy | 1 | 1972 | 863 | 0.000 |
Why?
|
| Biological Transport | 1 | 1971 | 2085 | 0.000 |
Why?
|
| Plasma | 1 | 1970 | 585 | 0.000 |
Why?
|
| Cell Count | 1 | 1970 | 1832 | 0.000 |
Why?
|
| Head | 1 | 1970 | 926 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1973 | 1662 | 0.000 |
Why?
|
| Testosterone | 1 | 1973 | 2491 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1963 | 11519 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1969 | 923 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1969 | 1554 | 0.000 |
Why?
|
| Macrophages | 1 | 1975 | 5799 | 0.000 |
Why?
|
| Protein Binding | 1 | 1971 | 9343 | 0.000 |
Why?
|
| Inflammation | 1 | 1974 | 10873 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1976 | 15832 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1971 | 26422 | 0.000 |
Why?
|